The tweet was deleted by the author.
But we saved everything 🙂.
Cullinan Therapeutics announced that Chief Scientific Officer Jennifer Michaelson, PhD, will participate in a discussion at the Longwood Healthcare Leaders MITCEO Conference next Tuesday.
The event brings together prominent leaders from the life sciences sector to explore strategies that accelerate the development of new medicines for patients. Michaelson's involvement highlights the company's commitment to scientific advancement and collaboration within the healthcare industry.
Cullinan Therapeutics has recently outlined a novel biomarker approach aimed at immune reset in autoimmune diseases. The company has also pursued the development of T cell engager therapies targeting B cells. These initiatives reflect Cullinan's advancing research in autoimmune treatment.